Rooti Rx ECG Event Recorder, Rooti Link APP Software
Rooti Labs Ltd. • Cardiovascular • 11/07/2017
Device Purpose
The Rooti Rx System is a wearable, single-lead electrocardiography event recorder designed for ambulatory patients to capture cardiac electrical activity for later analysis by healthcare professionals. Its methodology relies on skin-surface electrodes to sense these cardiac signals, which are then processed, stored on the device, and wirelessly transmitted to an iOS application for remote review.
Summary
The Rooti Rx System, developed by Rooti Labs Ltd., is a wearable medical device designed for patients to record single-lead electrocardiography (ECG) data in non-critical care settings, such as at home or in the workplace. The system comprises the Rooti Rx recorder, a patch, a charging dock, and the Rooti Link APP software for iOS devices. Its primary function is to capture and store ECG signals using standard, disposable ECG electrodes. This data is intended for subsequent post-analysis by medical professionals to aid in cardiovascular assessment for general care patients aged 21 years and older. The Rooti Rx device operates based on the scientific principle of detecting low-level electrical pulses generated by the heart, measurable on the skin's surface. It captures these signals as a single ECG channel with a 24-bit resolution and a 500 Hz sampling rate, storing up to 7 days of continuous data. This recorded ECG information is then transmitted wirelessly via Wi-Fi to a medical professional's iOS device using the Rooti Link APP, facilitating remote review and post-analysis at a later time. The system is designed to be water-resistant, lightweight (14g), and compact, utilizing a rechargeable battery for power.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. What is the specified battery life of the Rooti Rx device during continuous single-lead ECG recording, and how does this impact usability for the claimed 7-day data storage capacity?; How does the Rooti Link APP software facilitate the medical professional's workflow for ECG data review and post-analysis, including any specific analytical tools or features provided within the app?; What validation studies were conducted to support the accuracy of the 24-bit ECG resolution and 500 Hz sampling rate in capturing clinically relevant ECG morphologies and arrhythmias compared to standard clinical ECG systems?; Given the Wi-Fi transmission to an iOS device, what specific data security and privacy measures (e.g., encryption, authentication) are implemented to protect patient ECG data during storage on the device, transmission, and on the iOS application, aligning with healthcare data regulations?; How does the device's performance, particularly signal quality and artifact rejection, fare in diverse real-world ambulatory conditions (e.g., varying activity levels, different body types) for patients aged 21 and older?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class C (software safety classification); Authorized before §524B enforcement
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of SaaSBOM, CBOM detected in AI-generated device summary.
• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.
• Not detected in AI-generated device summary: SBOM, ML-BOM, HBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly